(Q42546339)

2 November 2017

Regulation of the signal transduction program by drugs (English)

1 reference

2 November 2017

Weber G

1

1 reference

2 November 2017

Shen F

2

1 reference

2 November 2017

Prajda N

3

1 reference

2 November 2017

Yang H

4

1 reference

2 November 2017

Li W

5

1 reference

2 November 2017

Yeh A

6

1 reference

2 November 2017

Csokay B

7

1 reference

2 November 2017

Olah E

8

1 reference

2 November 2017

Look KY

9

1 reference

2 November 2017

language of work or name

1 reference

1 January 1997

1 reference

Advances in Enzyme Regulation

2 November 2017

1 reference

2 November 2017

37

1 reference

2 November 2017

35-55

1 reference

Coordinated increase in activities of the signal transduction enzymes PI kinase and PIP kinase in human cancer cells.

2 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2896%2900025-8

7 January 2021

Quercetin down-regulates signal transduction in human breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2896%2900025-8

7 January 2021

Linkage of reduction in 1-phosphatidylinositol 4-kinase activity and inositol 1,4,5-trisphosphate concentration in human ovarian carcinoma cells treated with quercetin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2896%2900025-8

7 January 2021

Regulation of signal transduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2896%2900025-8

7 January 2021

Inhibition by tiazofurin of inosine 5'-phosphate dehydrogenase (IMP DH) activity in extracts of ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2896%2900025-8

7 January 2021

Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2896%2900025-8

7 January 2021

Current issues in the regulation of signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2896%2900025-8

7 January 2021

IMP dehydrogenase, an enzyme linked with proliferation and malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2896%2900025-8

7 January 2021

Key enzymes of IMP metabolism: Transformation- and proliferation-linked alterations in gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2896%2900025-8

7 January 2021

Enzymology of cancer cells (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2896%2900025-8

7 January 2021

Enzymology of cancer cells (second of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2896%2900025-8

7 January 2021

Tiazofurin: biological effects and clinical uses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2896%2900025-8

7 January 2021

Tiazofurin down-regulates expression of c-Ki-ras oncogene in a leukemic patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2896%2900025-8

7 January 2021

Molecular mechanisms in the antiproliferative action of quercetin.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2896%2900025-8

7 January 2021

Screening of phosphatidylinositol kinase inhibitors from Streptomyces

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2896%2900025-8

7 January 2021

Effects of inhibitors of protein tyrosine kinase activity and/or phosphatidylinositol turnover on differentiation of some human myelomonocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2896%2900025-8

7 January 2021

Effects of genistein, a tyrosine kinase inhibitor, on platelet functions. Genistein attenuates thrombin-induced Ca2+ mobilization in human platelets by affecting polyphosphoinositide turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2896%2900025-8

7 January 2021

10.1016/S0065-2571(96)00025-8

Identifiers

DOI

1 reference

2 November 2017

1 reference